Page last updated: 2024-10-26

eicosapentaenoic acid ethyl ester and Dyskinesia, Drug-Induced

eicosapentaenoic acid ethyl ester has been researched along with Dyskinesia, Drug-Induced in 1 studies

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Puri, BK1
Bydder, GM1
Counsell, SJ1
Corridan, BJ1
Richardson, AJ1
Hajnal, JV1
Appel, C1
Mckee, HM1
Vaddadi, KS1
Horrobin, DF1

Trials

1 trial available for eicosapentaenoic acid ethyl ester and Dyskinesia, Drug-Induced

ArticleYear
MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment.
    Neuroreport, 2002, Jan-21, Volume: 13, Issue:1

    Topics: Aged; Atrophy; Brain; Double-Blind Method; Dyskinesia, Drug-Induced; Eicosapentaenoic Acid; Female;

2002